License Fees for a Compulsory License – Isentress II – German Federal Patent Court

09/05/2018 | Dr. Raphael Bösl

As a follow-up to our posts of July 12, 2017 and August 31, 2017. Below please find an English translation of the Guiding Principles of a decision of the German Federal Patent Court concerning the assessment of license fees for a compulsory license for a medicament against AIDS (Isentress/Raltegravir). Also posted is the entire decision in German for your convenience. Our Munich partner, Fritz Lahrtz, was one of the leading attorneys in this case.


Rufen Sie uns an oder schreiben Sie uns.
Wir beraten Sie gerne.


+49 621 42 271-0 (Mannheim)

+49 211 157756-0 (Düsseldorf)